Neuca buys majority stake in Bioscience

Neuca’s subsidiary, Neuca Med, has acquired a 64.3 percent stake in Bioscience, a clinical research company. The transaction will strengthen the group’s competences in the field of clinical research and will contribute to the development of the whole Neuca’s health care segment,” a statement read. The agreement stipulates that Neuca Med may increase its stake…

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It